Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jun;69(6):963-74.
doi: 10.1002/ana.22354. Epub 2011 Mar 17.

Collaterals dramatically alter stroke risk in intracranial atherosclerosis

Affiliations
Clinical Trial

Collaterals dramatically alter stroke risk in intracranial atherosclerosis

David S Liebeskind et al. Ann Neurol. 2011 Jun.

Abstract

Objective: Stroke risk due to intracranial atherosclerosis increases with degree of arterial stenosis. We evaluated the previously unexplored role of collaterals in modifying stroke risk in intracranial atherosclerosis and impact on subsequent stroke characteristics.

Methods: Collateral flow was graded in blind fashion on 287 of 569 baseline angiograms (stenoses of 50-99% and adequate collateral views) in the Warfarin--Aspirin Symptomatic Intracranial Disease (WASID) trial. Statistical models predicted stroke in the symptomatic arterial territory based on collateral flow grade, percentage of stenosis, and previously demonstrated independent covariates.

Results: Across all stenoses, extent of collaterals was a predictor for subsequent stroke in the symptomatic arterial territory (hazard ratio [HR] none vs good, 1.14; 95% confidence interval [CI], 0.39-3.30; poor vs good, 4.36; 95% CI, 1.46-13.07; p < 0.0001). For 70 to 99% stenoses, more extensive collaterals diminished risk of subsequent territorial stroke (HR none vs good, 4.60; 95% CI, 1.03-20.56; poor vs good, 5.90; 95% CI, 1.25-27.81; p = 0.0427). At milder degrees of stenoses (50-69%), presence of collaterals was associated with greater likelihood of subsequent stroke (HR none vs good, 0.18; 95% CI, 0.04-0.82; poor vs good, 1.78; 95% CI, 0.37-8.57; p < 0.0001). In multivariate analyses, extent of collaterals was an independent predictor for subsequent stroke in the symptomatic arterial territory (HR none vs good, 1.62; 95% CI, 0.52-5.11; poor vs good, 4.78; 95% CI, 1.55-14.7; p = 0.0019).

Interpretation: Collateral circulation is a potent determinant of stroke risk in intracranial atherosclerosis, demonstrating a protective role with severe stenoses and identifying more unstable milder stenoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Protective effect of collateral circulation offsets risk of territorial stroke in severe stenoses. (A) Cerebellar hemispheric collaterals from posterior inferior cerebellar territory to the superior cerebellar territory provide flow downstream from a proximal basilar stenosis. (B) Leptomeningeal collaterals from anterior and posterior cerebral augment flow beyond a proximal middle cerebral artery stenosis.
Figure 2
Figure 2
Collaterals avert stroke in severe stenosis yet may be a marker of hemodynamic impairment and elevated stroke risk in moderate stenoses. (A) Robust collaterals in severe MCA stenosis prevent stroke whereas (B) brisk collateral filling in a moderate distal vertebral stenosis may be an ominous marker.
Figure 3
Figure 3
Kaplan-Meier curves for the endpoint of stroke in the territory of the symptomatic intracranial stenosis based on collateral status for severe stenoses. The presence of good collaterals diminishes risk of territorial stroke.
Figure 4
Figure 4
Kaplan-Meier curves for the endpoint of stroke in the territory of the symptomatic intracranial stenosis based on collateral status for moderate stenoses. The presence of any collaterals, good or poor, serve as an ominous marker of future stroke in cases of moderate stenosis.

References

    1. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396–2399. - PubMed
    1. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1:158–159. - PubMed
    1. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316. - PubMed
    1. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13–22. - PubMed
    1. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995;45:1488–1493. - PubMed

Publication types

MeSH terms

Substances